Detection of oxacillin-susceptible mecA-positive Staphylococcus aureus isolates by use of chromogenic medium MRSA ID

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 318-319

  Kumar, V Anil ^a   Steffy, Katherin ^a   Chatterjee, Maitrayee ^a   Sugumar, Madhan ^b   Dinesh, Kavitha R ^a   Manoharan, Anand ^b   Karim, Shamsul ^a   Biswas, Raja ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; BETA LACTAM; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; METICILLIN; OXACILLIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CEFOXITIN; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXACILLIN; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84871699556     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01040-12     Document Type: Article

References (16)

1. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Chambers HF, Sachdeva M. 1990. Binding of β-lactam antibiotics topenicillin-binding proteins in methicillin-resistant Staphylococcus aureus.J. Infect. Dis. 161:1170-1176. (Pubitemid 20177877)
3. Chambers HF. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791. (Pubitemid 27477734)
4. Cuirolo A, Canigia LF, Gardella N, Fernández S, Gutkind G, Rosato A, Mollerach M. 2011. Oxacillin- and cefoxitin-susceptible meticillinresistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents. 37:178-179.
5. Hososaka Y, Hanaki H, Endo H, Suzuki Y, Nagasawa Z, Otsuka Y, Nakae T, Sunakawa K. 2007. Characterization of oxacillin-susceptible mecA positive Staphylococcus aureus: a new type of MRSA. J. Infect. Chemother. 13:79-86. (Pubitemid 46669295)
6. Ikonomidis A, Michail G, Vasdeki A, Labrou M, Karavasilis V, Stathopoulos C, Maniatis AN, Pournaras S. 2008. In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 52:3905-3908.
7. Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:231-238. (Pubitemid 30060711)
8. Oliveira DC, de Lencastre H. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161. (Pubitemid 34665910)
9. Petinaki E, Kontos F, Maniatis AN. 2002. Emergence of two oxacillin-susceptible mecA-positive Staphylococcus aureus clones in a Greek hospital. J. Antimicrob. Chemother. 50:1090-1091. (Pubitemid 36032839)
10. Sakoulas G, Gold HS, Venkataraman L, DeGirolami PC, Eliopoulos GM, Qian Q. 2001. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J. Clin. Microbiol. 39:3946-3951. (Pubitemid 33029765)
11. Strommenger B, Kettlitz C, Werner G, Witte W. 2003. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J. Clin. Microbiol. 41:4089-4094. (Pubitemid 37099669)
12. Kampf G, Adena S, Ruden H, Weist K. 2003. Inducibility and potential role of mecA-gene-positive oxacillin-susceptible Staphylococcus aureusfrom colonized healthcare workers as a source for nosocomial infections. J. Hosp. Infect. 54:124-129. (Pubitemid 38002010)
13. Van Vaerenbergh K, Cartuyvels R, Coppens G, Frans J, Van den Abeele AM, De Beenhouwer H, Group BILULU. 2010. Performance of a new chromogenic medium, BBL CHROMagar MRSA II (BD), for detection of methicillin-resistant Staphylococcus aureus in screening samples. J. Clin. Microbiol. 48:1450-1451.
14. Labrou M, Michail G, Ntokou E, Pittaras TE, Pournaras S, Tsakris A. 2012. Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model. Antimicrob. Agents Chemother. 56:3388-3391.
15. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132. (Pubitemid 30265628)
16. Saeed K, Dryden M, Parnaby R. 2010. Oxacillin-susceptible MRSA, the emerging MRSA clone in the UK? J. Hosp. Infect. 76:267-268.